Compound ID | 944

Update compound information

CP-67,015

Class: Quinolone

Details of activity: The activity of this compound is of the same magnitude as norfloxacin and ciprofloxacin
Institute where first reported: Pfizer, USA
Year first mentioned: 1987
Highest developmental phase: Preclinical
Development status: Inactive
Reason Dropped: Dropped due to genotoxicity [inhibitor of human Topoisomerase II]- (LS, 2)
Chemical structure(s):
Click here for structure editor
Molecular weight: 330.29
Iso. SMILES: CCN1C=C(C(=O)C2=CC(=C(C(=C21)F)C3=CC=NC=C3)F)C(=O)O
InChI Key: AVTJRMCCKOBMQP-UHFFFAOYSA-N
Can. SMILES: CCN1C=C(C(=O)C2=C1C(=C(C3=CC=NC=C3)C(=C2)F)F)C(=O)O
InChI: InChI=1S/C17H12F2N2O3/c1-2-21-8-11(17(23)24)16(22)10-7-12(18)13(14(19)15(10)21)9-3-5-20-6-4-9/h3-8H,2H2,1H3,(H,23,24)
External links:
PubChem link: https://pubchem.ncbi.nlm.nih.gov/compound/127557
Citations:
  • https://books.google.co.uk/books?id=CejlBwAAQBAJ&pg=PA169&lpg=PA169&dq=CP-67,015&source=bl&ots=FCGR_hdFCM&sig=OD14-30WcpuTGDJbfNhGLEqvGIA&hl=en&sa=X&ei=D5R1VZ2DB8rnUuXRg4gN&ved=0CC0Q6AEwAw#v=onepage&q=CP-67%2C015&f=false

  • AntibioticDB is supported by GARDP.

    If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

    The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.